Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Florian Johannes Fintelmann, M.D.

Co-Author

This page shows the publications co-authored by Florian Fintelmann and Inga Lennes.
Connection Strength

0.589
  1. Fintelmann FJ, Gottumukkala RV, McDermott S, Gilman MD, Lennes IT, Shepard JO. Lung Cancer Screening: Why, When, and How? Radiol Clin North Am. 2017 Nov; 55(6):1163-1181.
    View in: PubMed
    Score: 0.200
  2. Fintelmann FJ, Bernheim A, Digumarthy SR, Lennes IT, Kalra MK, Gilman MD, Sharma A, Flores EJ, Muse VV, Shepard JA. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program. Radiographics. 2015 Nov-Dec; 35(7):1893-908.
    View in: PubMed
    Score: 0.174
  3. Fisch AS, Fintelmann FJ, Garcia-Moliner ML, Gaissert HA, Lennes I, Butera JN, Stone JR, Hariri LP. Systemic Amyloidosis Mimicking Lung Cancer. Am J Respir Crit Care Med. 2020 01 01; 201(1):107-108.
    View in: PubMed
    Score: 0.058
  4. Madariaga ML, Lennes IT, Best T, Shepard JO, Fintelmann FJ, Mathisen DJ, Gaissert HA. Multidisciplinary selection of pulmonary nodules for surgical resection: Diagnostic results and long-term outcomes. J Thorac Cardiovasc Surg. 2020 04; 159(4):1558-1566.e3.
    View in: PubMed
    Score: 0.057
  5. Dagogo-Jack I, Azzolli CG, Fintelmann F, Mino-Kenudson M, Farago AF, Gainor JF, Jiang G, Piotrowska Z, Heist RS, Lennes IT, Temel JS, Mooradian MJ, Lin JJ, Digumarthy SR, Batten JM, Robinson H, Nose V, Rivera M, Nardi V, Dias-Santagata D, Le LP, Sequist LV, Pitman M, Shepard JO, Shaw AT, Iafrate AJ, Lennerz JK. Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer. JCO Precis Oncol. 2018; 2018.
    View in: PubMed
    Score: 0.053
  6. Piotrowska Z, Stirling K, Heist R, Campo M, Rizzo C, Digumarthy SR, Lanuti M, Fintelmann FJ, Lennes I, Farago A, Gainor J, Azzoli CG, Temel J, Mino-Kenudson M, Dias-Santagata D, Corcoran R, Shaw A, Engelman JA, Hata A, Sequist LV. Heterogeneity and Variation in Resistance Mechanisms Among 223 Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Patients With > 1 Post-Resistance Biopsy. Int J Radiat Oncol Biol Phys. 2017 May 01; 98(1):220.
    View in: PubMed
    Score: 0.048
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.